# Total/Subtotal Colectomy in Ovarian Cancer

> **NCT02595021** · PHASE2 · UNKNOWN · sponsor: **Shanghai Gynecologic Oncology Group** · enrollment: 80 (estimated)

## Conditions studied

- Epithelial Ovarian Cancer
- Fallopian Tube Cancer
- Primary Peritoneal Carcinoma
- Secondary Malignant Neoplasm of Large Intestine

## Interventions

- **PROCEDURE:** Total or Subtotal Colectomy
- **PROCEDURE:** Other Bowel Resection

## Key facts

- **NCT ID:** NCT02595021
- **Lead sponsor:** Shanghai Gynecologic Oncology Group
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2016-07-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02595021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02595021, "Total/Subtotal Colectomy in Ovarian Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02595021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*